FDAnews
www.fdanews.com/articles/158522-west-ward-investigations-into-metal-contamination-don-t-measure-up

West-Ward Investigations into Metal Contamination Don’t Measure Up

September 10, 2013
West-Ward Pharmaceuticals has received a Form 483 for lax investigations into metal contaminants and batch deficiencies following an inspection of its Eatontown, N.J., plant. Investigators found that West-Ward failed to identify all potential sources of metal contamination for lots of lisinopril and hydrochlorothiazide 20 mg/25 mg tablets, carisoprodol 350 mg, prednisone, USP 10 mg tablets and lisinopril 40 mg tablets.
Drug GMP Report